Sinocelltech Group Ltd

688520

Company Profile

  • Business description

    Sinocelltech Group Ltd is engaged in development and industrialization of biopharmaceutical products such as monoclonal antibodies, recombinant proteins and vaccines. The company has developed technology platforms in protein expression vectors, cell line development, serum-free medium development, stoichiometrically controlled fed-batch cell culture, process scale-up, and protein purification. Its capacities include stable CHO cell line development, cell banking and certification, serum-free and protein-free culture medium development, fed-batch cell culture process development, optimization, and process scale-up; protein purification development, and large scale production.

  • Contact

    Kechuang Seventh Street
    Beijing Economic and Technological Development Zone
    Room 307, Building 5, Courtyard 31
    Beijing100176
    CHN

    T: +86 1058628288

    http://www.sinocelltech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    2,277

Stocks News & Analysis

stocks

ChatGPT enters the retail space and one company surges

Investors cheer the ability to purchase directly from ChatGPT.
stocks

Alibaba fair value increases by 49%

Stronger-than-expected AI demand internationally and domestically.
stocks

Our fair value on ASX share falls by half

Downgrading our estimates due to lower growth.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,135.9019.50-0.21%
CAC 407,895.9415.070.19%
DAX 4023,880.72135.660.57%
Dow JONES (US)46,397.8981.820.18%
FTSE 1009,350.4350.590.54%
HKSE26,855.56232.680.87%
NASDAQ22,660.0168.860.30%
Nikkei 22544,932.63111.12-0.25%
NZX 50 Index13,292.36159.801.22%
S&P 5006,688.4627.250.41%
S&P/ASX 2008,848.8020.50-0.23%
SSE Composite Index3,882.7820.250.52%

Market Movers